NSE
Anlon Healthcare LimitedAHCL
Anlon Healthcare Limited is an Indian pharmaceutical company focused on the manufacturing and distribution of healthcare products.
| Key products | Pharmaceuticals, medical devices |
|---|---|
| Geography | India, with regional presence in Southeast Asia |
| Competitors | Cadila Healthcare, Dr. Reddy's Laboratories |
AI-generated overview — verify before relying on it.
Net institutional flow
−₹19.3 Cr
Institutional buyers
5 in / 7 out
High-impact filings
0 · tilt Neutral
Next corporate action
Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share
ex 2026-04-24
Competitive landscape — the read
vs most-traded names| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +₹41.3 Cr | 331 | — | — | — | — |
| 2 | ATALREAL | +₹7.4 Cr | 363 | — | — | — | — |
| 3 | GATECH | +₹0.4 Cr | 298 | — | — | — | — |
| 4 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 5 | QUADFUTURE | −₹9 Cr | 571 | — | — | — | — |
| 6 | AHCLThis | −₹19.3 Cr | 33 | — | — | — | — |
| 7 | MOBIKWIK | −₹150.9 Cr | 975 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Weaknesses
- • [object Object]
- • [object Object]
Opportunities
- • [object Object]
- • [object Object]
Threats
- • [object Object]
- • [object Object]
AI-generated from our data — verify before relying on it.
Timeline — AHCL day by day
- 2026-06-11FilingAnlon Healthcare Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (LODR) ReUpdates
- 2026-06-09BulkSELL · ₹14.4 CrNEOMILE GROWTH FUND-SERIES I
- 2026-06-09FilingAnlon Healthcare Limited has informed the Exchange regarding Media Interaction of Chairman & Managing DirectorManagement
- 2026-06-09FilingAnlon Healthcare Limited has informed the Exchange about TranscriptInvestor Call
- 2026-04-24BulkSELL · ₹3.4 CrNEOMILE GROWTH FUND-SERIES I
- 2026-04-24ActionFace Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per ShareSplit
- 2026-04-24ActionBonus 1:1Bonus
- 2026-01-21BulkSELL · ₹5.1 CrNEOMILE CORPORATE ADVISORY LIMITED
- 2026-01-21BulkBUY · ₹5 CrNEOMILE GROWTH FUND-SERIES I
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
- 2UpdatesNeutral
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 Invitation for TV Interview on NDTV Profit.'.
Source PDF → - 4
- 2
4 deals · 2026-01-21 → 2026-06-09
| Date | Counterparty | Investor type | Side | Value |
|---|---|---|---|---|
| 2026-06-09 | NEOMILE GROWTH FUND-SERIES I | Institution | SELL | ₹14.4 Cr |
| 2026-04-24 | NEOMILE GROWTH FUND-SERIES I | Institution | SELL | ₹3.4 Cr |
| 2026-01-21 | NEOMILE CORPORATE ADVISORY LIMITED | Institution | SELL | ₹5.1 Cr |
| 2026-01-21 | NEOMILE GROWTH FUND-SERIES I | Institution | BUY | ₹5 Cr |
4 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
Financial results
None yet.
Calls & transcripts
News & chatter on AHCL
RSS News
0No recent news.
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.